Holder evidence
50
SEC ownership of EXELIXIS, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000939767.
Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Latest evidence
27 May 2026
- CIK
- 0000939767
- Symbol
- EXEL on Nasdaq
- Location
- Alameda, CA
- SEC evidence mix
- 13F, 13D/G, and 3/4/5
- Lead holder
- BlackRock, Inc.
- Latest large-stake holder
- BlackRock, Inc.
- Latest evidence date
- 27 May 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of EXELIXIS, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
50
Latest as of
27 May 2026
13F
13D/G
3/4/5
Lead comparable stake: 10%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Rank 1 holder
BlackRock, Inc.
13F
13D/G
- Ownership
- 10%
- Position
- $1.32B
Rank 2 holder
Farallon Capital Partners, L.P.
13D/G
- Ownership
- 5.9%
- Position
- $650.22M
Rank 3 holder
AQR CAPITAL MANAGEMENT LLC
13D/G
13F
- Ownership
- 5.1%
- Position
- $601.79M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
10%
from 13D/G
|
$1,321,711,509
30,816,309 shares
|
— | 31 Mar 2026 |
| Farallon Capital Partners, L.P. |
13D/G
Dapice Joshua J.
|
5.9%
|
$650,216,205
15,709,500 shares
|
-$121,107,140 | 01 Jan 2026 |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
5.1%
|
$601,788,575
13,658,388 shares
|
$0 | 31 Dec 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.1%
|
$567,573,964
13,233,247 shares
|
$0 | 31 Mar 2026 |
| Michael Morrissey |
3/4/5
President and CEO, Director
|
1.3%
|
$145,142,461
3,384,063 shares
|
— | 15 May 2026 |
| Stelios Papadopoulos |
3/4/5
Director
|
0.46%
|
$51,364,849
1,197,595 shares
|
-$4,355,000 | 27 May 2026 |
| Christopher J. Senner |
3/4/5
EVP and CFO
|
0.37%
|
$47,732,639
955,040 shares
|
-$4,556,048 | 15 May 2026 |
| Jeffrey Hessekiel |
3/4/5
EVP & General Counsel
|
0.27%
|
$32,059,538
694,395 shares
|
— | 15 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$40,968,038.
Buys
$1,187,235
Insiders: 1
Sells
$42,155,273
Insiders: 12
Net
-$40,968,038
Shares: -918,897
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 27,532
Shares: 946,429
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 205,433 | $0 | $9,930,259 | -$9,930,259 |
| 3-6 | 0 | 469,388 | $0 | $20,604,572 | -$20,604,572 |
| 6-9 | 27,532 | 245,235 | $1,187,235 | $10,490,619 | -$9,303,384 |
| 9-12 | 0 | 26,373 | $0 | $1,129,823 | -$1,129,823 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 27 reporting-owner rows connected to EXELIXIS, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
27
Lead holder
Michael Morrissey
Net 12M change
-$40,968,038
Latest report
27 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michael Morrissey | President and CEO, Director | $145,142,461 | Median | 15 May 2026 | ||
| David Edward Johnson | Director | $67,687,536 | +$1,187,235 | +1.8% | Mixed | 27 May 2026 |
| Stelios Papadopoulos | Director | $51,364,849 | -$4,355,000 | -7.8% | Median | 27 May 2026 |
| Christopher J. Senner | EVP and CFO | $47,732,639 | -$4,556,048 | -8.7% | Mixed | 15 May 2026 |
| Jeffrey Hessekiel | EVP & General Counsel | $32,059,538 | Mixed | 15 May 2025 | ||
| Dana Aftab | EVP, Research and Development | $30,195,472 | -$7,701,254 | -20% | Mixed | 26 May 2026 |
| Amy C. Peterson | EVP Prod Dev & Med Aff & CMO | $21,161,419 | Filing P/S | 15 May 2025 | ||
| Patrick J. Haley | EVP, Commercial | $17,813,948 | -$7,597,269 | -30% | Filing P/S | 20 May 2026 |
| Gisela Schwab | Pres, Prod Dev & Med Aff & CMO | $16,092,480 | Mixed | 26 Jul 2021 | ||
| Jack L. Wyszomierski | Director | $12,365,573 | -$4,706,935 | -28% | Median | 27 May 2026 |
| Peter Lamb | EVP, Scientific Strategy & CSO | $9,785,520 | Mixed | 15 Dec 2022 | ||
| Lance Willsey | Director | $9,702,127 | Mixed | 26 May 2022 | ||
| Vicki L. Goodman | EVP, Prod Dev & Med Aff &CMO | $7,032,970 | Mixed | 03 Apr 2023 | ||
| Charles Cohen | Director | $5,975,033 | Mixed | 31 Dec 2021 | ||
| Brenda Hefti | SVP and General Counsel | $5,597,573 | -$1,154,264 | -17% | Mixed | 15 May 2026 |
| George Poste | Director | $5,455,565 | -$2,742,600 | -33% | Median | 27 May 2026 |
| Maria C. Freire | Director | $4,682,987 | -$949,164 | -17% | Median | 27 May 2026 |
| Tomas J. Heyman | Director | $2,172,335 | Median | 27 May 2026 | ||
| Marchesi Vincent T. | Director | $2,148,589 | Mixed | 26 May 2022 | ||
| Bob Oliver | Director | $1,264,697 | -$1,325,339 | -51% | Median | 27 May 2026 |
Recent insider transactions for EXELIXIS, INC.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Stelios Papadopoulos | EXEL | Common Stock | Award | 0.7% | 8,367 | 1,197,595 | 27 May 2026 | Direct | ||
| Tomas J. Heyman | EXEL | Common Stock | Award | 19.8% | 8,367 | 50,649 | 27 May 2026 | Direct | ||
| Sue Gail Eckhardt | EXEL | Common Stock | Award | 47.8% | 8,367 | 25,891 | 27 May 2026 | Direct | ||
| Julie Smith | EXEL | Common Stock | Award | 40.6% | 8,367 | 28,957 | 27 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Common Stock | Award | 8.3% | 8,367 | 109,186 | 27 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Common Stock | Award | 47.8% | 8,367 | 25,891 | 27 May 2026 | Direct | ||
| Bob Oliver | EXEL | Common Stock | Award | 39.6% | 8,367 | 29,487 | 27 May 2026 | Direct | ||
| Jack L. Wyszomierski | EXEL | Common Stock | Award | 2.99% | 8,367 | 288,309 | 27 May 2026 | Direct | ||
| George Poste | EXEL | Common Stock | Award | 7.04% | 8,367 | 127,199 | 27 May 2026 | Direct | ||
| Johnson David Edward | EXEL | Option (right to buy) | Award | 19,133 | 19,133 | 27 May 2026 | Direct | |||
| David Edward Johnson | EXEL | Option (right to buy) | Award | 19,133 | 19,133 | 27 May 2026 | Direct | |||
| Dana Aftab | EXEL | Common Stock | Sale | -6.81% | $2,187,758 | $50.35 | -43,451 | 594,741 | 26 May 2026 | Direct |
| Patrick J. Haley | EXEL | Common Stock | Sale | -8.24% | $1,599,399 | $49.81 | -32,110 | 357,638 | 20 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | 6.6% | 124,047 | 2,004,327 | 18 May 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -8.35% | -124,047 | 1,362,008 | 18 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Sale | -3.54% | $1,745,050 | $50.00 | -34,901 | 952,317 | 18 May 2026 | Direct |
| Brenda Hefti | EXEL | Common Stock | Sale | -5.84% | $332,641 | $50.21 | -6,625 | 106,762 | 18 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Tax liability | -7.96% | -128,497 | 1,486,055 | 15 May 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Tax liability | -3.98% | -40,892 | 987,218 | 15 May 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Tax liability | -7.86% | -33,265 | 389,748 | 15 May 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Tax liability | -5.35% | -6,411 | 113,387 | 15 May 2026 | Direct | ||
| Dana Aftab | EXEL | Common Stock | Tax liability | -4.57% | -30,578 | 638,192 | 15 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Common Stock | Sale | -30.6% | $373,646 | $48.45 | -7,712 | 17,524 | 07 May 2026 | Direct |
| Mary C. Beckerle | EXEL | Common Stock | Options Exercise | 18% | 3,856 | 25,236 | 07 May 2026 | Direct | ||
| Mary C. Beckerle | EXEL | Option (right to buy) | Options Exercise | -23.1% | -3,856 | 12,854 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Common Stock | Sale | -17% | $949,164 | $46.00 | -20,634 | 100,819 | 07 May 2026 | Direct |
| Maria C. Freire | EXEL | Common Stock | Options Exercise | 20.5% | 20,634 | 121,453 | 07 May 2026 | Direct | ||
| Maria C. Freire | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 07 May 2026 | Direct | ||
| George Poste | EXEL | Common Stock | Sale | -33.6% | $2,742,600 | $45.71 | -60,000 | 118,832 | 07 May 2026 | Direct |
| Michael Morrissey | EXEL | Common Stock | Gift | -5.51% | -109,676 | 1,880,280 | 06 May 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Award | 8.44% | 52,018 | 668,124 | 26 Feb 2026 | Direct | ||
| Christopher J. Senner | EXEL | Common Stock | Award | 5.33% | 52,018 | 1,028,110 | 26 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Award | 24% | 23,119 | 119,631 | 26 Feb 2026 | Direct | ||
| Patrick J. Haley | EXEL | Common Stock | Award | 10.6% | 40,459 | 422,367 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Award | 11% | 160,437 | 1,614,552 | 26 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -4.8% | -100,278 | 1,989,956 | 24 Feb 2026 | By Trust | ||
| Dana Aftab | EXEL | Common Stock | Sale | -7.22% | $2,132,351 | $44.50 | -47,918 | 616,106 | 24 Feb 2026 | Direct |
| Dana Aftab | EXEL | Common Stock | Sale | -4.31% | $1,324,868 | $44.35 | -29,873 | 664,024 | 19 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Sale | -26.2% | $4,382,252 | $44.01 | -99,574 | 279,942 | 18 Feb 2026 | Direct |
| Jack L. Wyszomierski | EXEL | Common Stock | Options Exercise | 5.75% | 20,634 | 379,516 | 18 Feb 2026 | Direct | ||
| Jack L. Wyszomierski | EXEL | Option (right to buy) | Options Exercise | -100% | -20,634 | 0 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Common Stock | Sale | -75.7% | $2,849,200 | $44.44 | -64,117 | 20,590 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Options Exercise | 11449.5% | 64,117 | 64,677 | 18 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Option (right to buy) | Options Exercise | -100% | -64,117 | 0 | 18 Feb 2026 | Direct | ||
| Michael Morrissey | EXEL | Common Stock | Gift | 6.37% | 125,094 | 2,090,234 | 18 Feb 2026 | By Trust | ||
| Michael Morrissey | EXEL | Common Stock | Gift | -7.92% | -125,094 | 1,454,115 | 18 Feb 2026 | Direct | ||
| Brenda Hefti | EXEL | Common Stock | Sale | -16.2% | $821,623 | $44.01 | -18,669 | 96,512 | 18 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Sale | -67.3% | $1,838,145 | $43.33 | -42,422 | 20,590 | 17 Feb 2026 | Direct |
| Julie Smith | EXEL | Common Stock | Options Exercise | 206% | 42,422 | 63,012 | 17 Feb 2026 | Direct | ||
| Julie Smith | EXEL | Option (right to buy) | Options Exercise | -100% | -42,422 | 0 | 17 Feb 2026 | Direct |
* indicates a reported price that failed the local validity check.